Cargando…
All Bruton’s tyrosine kinase inhibitors have similar efficacy and risks: No
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315179/ https://www.ncbi.nlm.nih.gov/pubmed/35437080 http://dx.doi.org/10.1177/13524585221091060 |